Merck Tbk - Asset Resilience Ratio

Latest as of June 2025: 6.75%

Merck Tbk (MERK) has an Asset Resilience Ratio of 6.75% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Merck Tbk to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rp68.00 Billion
≈ $3.98 Million USD Cash + Short-term Investments

Total Assets

Rp1.01 Trillion
≈ $59.02 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Merck Tbk's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Merck Tbk balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Merck Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Merck Tbk balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp0.00 0%
Short-term Investments Rp68.00 Billion 6.75%
Total Liquid Assets Rp68.00 Billion 6.75%

Asset Resilience Insights

  • Limited Liquidity: Merck Tbk maintains only 6.75% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Merck Tbk Industry Peers by Asset Resilience Ratio

Compare Merck Tbk's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for Merck Tbk (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Merck Tbk.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.93% Rp28.00 Billion
≈ $1.64 Million
Rp956.94 Billion
≈ $56.07 Million
+0.91pp
2023-12-31 2.02% Rp19.31 Billion
≈ $1.13 Million
Rp957.81 Billion
≈ $56.12 Million
-5.66pp
2022-12-31 7.67% Rp79.61 Billion
≈ $4.67 Million
Rp1.04 Trillion
≈ $60.80 Million
+2.37pp
2021-12-31 5.30% Rp54.40 Billion
≈ $3.19 Million
Rp1.03 Trillion
≈ $60.14 Million
-5.07pp
2020-12-31 10.37% Rp96.40 Billion
≈ $5.65 Million
Rp929.90 Billion
≈ $54.49 Million
+2.10pp
2019-12-31 8.27% Rp74.50 Billion
≈ $4.37 Million
Rp901.06 Billion
≈ $52.80 Million
--
2017-12-31 0.00% Rp0.00
≈ $0.00
Rp847.01 Billion
≈ $49.63 Million
--
2016-12-31 13.31% Rp99.00 Billion
≈ $5.80 Million
Rp743.93 Billion
≈ $43.59 Million
+11.01pp
2005-12-31 2.29% Rp5.00 Billion
≈ $292.98K
Rp218.03 Billion
≈ $12.78 Million
-3.40pp
2004-12-31 5.69% Rp11.41 Billion
≈ $668.59K
Rp200.47 Billion
≈ $11.75 Million
-5.96pp
2003-12-31 11.65% Rp23.33 Billion
≈ $1.37 Million
Rp200.33 Billion
≈ $11.74 Million
-7.11pp
2002-12-31 18.75% Rp32.32 Billion
≈ $1.89 Million
Rp172.34 Billion
≈ $10.10 Million
+5.13pp
2001-12-31 13.62% Rp22.17 Billion
≈ $1.30 Million
Rp162.72 Billion
≈ $9.53 Million
+12.47pp
2000-12-31 1.16% Rp1.50 Billion
≈ $87.89K
Rp129.68 Billion
≈ $7.60 Million
--
pp = percentage points

About Merck Tbk

JK:MERK Indonesia Drug Manufacturers - Specialty & Generic
Market Cap
$100.28 Million
Rp1.71 Trillion IDR
Market Cap Rank
#19286 Global
#338 in Indonesia
Share Price
Rp3820.00
Change (1 day)
-2.05%
52-Week Range
Rp2790.00 - Rp4380.00
All Time High
Rp4843.89
About

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more